Triple Combination Therapy Including Inhaled Treprostinil in High Risk Patients with Pulmonary Arterial Hypertension Unsuited for Infused Prostanoid Therapy

被引:0
|
作者
Swisher, J. [1 ]
Overton-Barnes, R. [1 ]
机构
[1] Ft Sanders Reg Med Ctr, Knoxville, FL USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A3814
引用
收藏
页数:1
相关论文
共 50 条
  • [21] The impact of comorbidities on inhaled treprostinil treatment in patients with pulmonary arterial hypertension
    Argula, Rahul
    Shapiro, Shelley
    El-Kersh, Karim
    Shen, Eric
    Kim, Hyoshin
    Broderick, Meredith
    Mclaughlin, Vallerie
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [22] Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Bourge, Robert C.
    Tapson, Victor F.
    Safdar, Zeenat
    Benza, Raymond L.
    Channick, Richard N.
    Rosenzweig, Erika B.
    Shapiro, Shelley
    White, Richard James
    McSwain, Christopher Shane
    Gotzkowsky, Stephen Karl
    Nelsen, Andrew C.
    Rubin, Lewis J.
    [J]. CARDIOVASCULAR THERAPEUTICS, 2013, 31 (01) : 38 - 44
  • [23] Advances in Prostanoid Infusion Therapy for Pulmonary Arterial Hypertension
    Doran, Aimee
    Harris, Stephanie
    Goetz, Brett
    [J]. JOURNAL OF INFUSION NURSING, 2008, 31 (06) : 336 - 345
  • [24] Abdominal paracentesis to overcome clinical worsening in severe pulmonary arterial hypertension (PAH) patients: first experience in three patients on combination therapy including Treprostinil
    Steringer-Mascherbauer, R.
    Sailer, T.
    Ebner, C.
    Fuegger, R.
    Marecek, I.
    Wittrich, S.
    Lummerstorfer, M.
    Nesser, H. J.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S39 - S39
  • [25] Abdominal Paracentesis To Overcome Clinical Worsening In Severe Pulmonary Arterial Hypertension (pah) Patients: First Experience In Three Patients On Combination Therapy Including Treprostinil
    Steringer-Mascherbauer, R.
    Sailer, T.
    Marecek, I.
    Nesser, H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [26] Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series
    Enderby, C. Y.
    Soukup, M.
    Al Omari, M.
    Zeiger, T.
    Burger, C.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (05) : 496 - 500
  • [27] Inhaled iloprost for therapy in pulmonary arterial hypertension
    Ewert, Ralf
    Glaeser, Sven
    Bollmann, Tom
    Schaeper, Christoph
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (02) : 145 - 152
  • [28] Upfront triple combination therapy in severe paediatric pulmonary arterial hypertension
    Haarman, Meindina G.
    Levy, Marilyne
    Roofthooft, Marcus T. R.
    Douwes, Johannes M.
    Vissia-Kazemier, Theresia R.
    Szezepanski, Isabelle
    Berger, Rolf M. F.
    Bonnet, Damien
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (01)
  • [29] Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study
    Sitbon, Olivier
    Jais, Xavier
    Savale, Laurent
    Cottin, Vincent
    Bergot, Emmanuel
    Macari, Elise Artaud
    Bouvaist, Helene
    Dauphin, Claire
    Picard, Francois
    Bulifon, Sophie
    Montani, David
    Humbert, Marc
    Simonneau, Gerald
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (06) : 1691 - 1697
  • [30] LESSONS LEARNED FROM TRIPLE COMBINATION THERAPY IN PULMONARY ARTERIAL HYPERTENSION
    Schuster, Sheeja
    Sulica, Roxana
    [J]. CHEST, 2019, 156 (04) : 493A - 494A